Media training for pharma and biotech is specialized coaching that prepares executives for pricing questions, FDA milestones, and clinical data coverage. Drug pricing, FDA approvals, clinical trial data, and patient access are daily news topics. When a reporter calls, the story is already framed. Jess trains pharma and biotech leaders to walk into those conversations with clarity, confidence, and a message that lands.
No industry faces more sustained public and media scrutiny than pharmaceutical and biotech companies. Pricing controversies, breakthrough therapy announcements, clinical trial results, and safety recalls all carry enormous reputational stakes. Your executives must be able to speak fluently to journalists, investors, regulators, and patients, often with the same message, in the same interview.
No story attracts more aggressive questioning than drug costs. Your executives need answers that are honest, defensible, and don't create new headlines.
Approval day generates a wave of media interest. Spokespeople must communicate efficacy, safety, and access plans without over-promising or triggering regulatory concerns.
Journalists and investors scrutinize trial data for spin. Your scientific leaders must explain results in plain language while maintaining complete scientific integrity.
A safety update or voluntary recall is a pivotal moment. How you communicate in the first 24 hours determines how the story resolves, and how much trust survives.
Develop honest, clear language around drug economics that acknowledges cost concerns while explaining value and investment in research.
Turn complex clinical data, biomarker results, and trial endpoints into accessible narratives without losing accuracy.
Respond to safety signals, recalls, and adverse event coverage with a message that demonstrates accountability and patient focus.
Communicate pipeline milestones, approval timelines, and commercial strategy in ways that build long-term investor and analyst trust.
"This whole session was extremely helpful. I needed to work in all areas... I really can see my improvement on-screen. This will help me tremendously professionally."
Pharmaceutical and biotech leaders present in some of the most consequential rooms in business: a regulatory advisory committee, a scientific congress, a partnering meeting, a national sales meeting, and a board reviewing a launch. Media training does not prepare anyone for those.
Presentation training does. Jess Todtfeld trains scientific and commercial leaders to build a presentation backward from the decision they need, replace a mechanism slide with an analogy the room repeats two weeks later, and hold composure through the question they hoped nobody would ask. Sessions are recorded, and the playback is where the change happens.
A regulatory advisory committee is a presentation with a public gallery and a vote at the end. Presenters rehearse the time-limited core presentation, the backup material, and the discipline of answering the question actually asked.
A congress slot is a short window to make years of work land with peers who have already seen forty posters that morning. Presenters practice structuring around clinical significance and delivering with authority.
Financing and partnering decisions turn on whether a room believes the science and the team. Leaders practice compressing a program into a narrative a nonscientist investor can evaluate and repeat.
A launch meeting sets the tone for an entire commercial effort. Leaders practice delivering strategy to a large room with energy and clarity, without reading the deck behind them.
Go deeper: presentation training for pharmaceutical executives, the high stakes presentation training methodology, the full presentation training program list, or presentation training questions answered.
Yes. Pricing is the most aggressive line of questioning in pharma, so it gets dedicated practice. Executives rehearse honest, defensible answers in recorded exercises with hostile follow-ups, learning to acknowledge patient cost concerns while explaining value and access programs without producing a damaging sound bite.
Yes. Sessions are built around regulatory reality. Practice scenarios use approved or sanitized material, and Jess coordinates with your legal, regulatory, and investor relations teams so nothing rehearsed creates off-label, promotional, or disclosure exposure. Spokespeople learn to bridge away from restricted topics gracefully.
Media training typically ranges from $1,000 to $15,000 per engagement depending on group size and scope. A focused session for one spokesperson sits at the lower end, while multi-day team workshops with recorded practice sit higher. See our media training questions page for a full breakdown of what drives pricing.
Every session is led by Jess Todtfeld, founder of Success in Media. Jess spent 13 years as a television producer at NBC, ABC, and Fox, and holds the Guinness World Record for the most media interviews given in 24 hours: 112 completed, 96 officially certified. He has trained pharmaceutical and biotech leaders to handle the industry's toughest questioning.
Yes. They are separate programs and pharmaceutical and biotech clients often book both. Media training prepares executives for reporters, pricing scrutiny, and safety coverage. Presentation training prepares them for advisory committees, scientific congresses, investor and partnering meetings, and launch meetings.
Yes. These are rehearsed as full performances under realistic conditions: a clock, a panel, and questions that jump between slides. Presenters practice leading with clinical significance, keeping the core presentation tight enough to leave time for discussion, and handing off cleanly between speakers. Every run is recorded for review.
Yes. Sessions use approved or sanitized material, and Jess works alongside your medical, legal, and regulatory teams. The training builds structure, delivery, and question handling; your review process keeps final control over what is said about the product.
Jess works with life sciences executives to ensure they can walk into any media situation, approval announcements, crisis moments, investor calls, with a message that holds up under pressure.
Get a Quick QuotePrefer to talk it through first? Speak with Jess
Steve S. Lin, M.D., Cardiologist
“I was able to learn how to focus my message and add sound bites. Everything was helpful. I was very pleased with the session.”
David DeYoung, Ross University
Jess holds a 5.0 Google rating and dozens of public LinkedIn recommendations, backed by 90+ named client results across industries.
Read our 5.0 Google reviews LinkedIn recommendations 90+ client results
